OUR PROVIDERS
AJH partners with a select group of world-class treatment facilities operating in legal jurisdictions around the world. Each provider meets our standards for medical supervision, clinical rigor, and athlete-centered care.
Every facility has been vetted by our scientific advisory board. Every program is delivered under medical supervision with full research protocols in place.
❋ Ambio Life Sciences
“The global leader in integrative ibogaine treatment”
Location:
Tijuana / Baja California, Mexico
Compounds:
Ibogaine
5-MeO-DMT
About
Ambio operates six private residential clinics in Baja California, each delivering world-class ibogaine care in a secure, medically supervised environment. Their facilities are equipped for advanced life support yet designed with the tranquility of a boutique retreat. Over 3,000 patients treated with 50+ years of combined clinical expertise across the founding team.
Why AJH Works With Ambio
Ambio co-authored a groundbreaking Nature Medicine publication with Stanford University on ibogaine for veteran traumatic brain injury. Their safety protocols are the gold standard in the field — and are now being adopted globally. They’re also featured in the Netflix documentary In Waves and War, following three U.S. veterans through their healing journey.
What Athletes Experience
Full medical screening and cardiac monitoring before, during, and after treatment
Individually tailored ibogaine or 5-MeO-DMT protocols based on condition and history
Somatic therapy, integration counseling, and peer support throughout the stay
Neuroimaging and bio-analysis as part of AJH’s research protocol
Post-treatment integration plan developed before departure
❋ Beōnd
“Clinical ibogaine treatment in a world-class setting”
Location:
Cancún, Mexico
Compounds:
Ibogaine
About
Beōnd is a clinical ibogaine treatment facility providing medically supervised programs in a premium clinical environment. Their team combines medical expertise with therapeutic support to deliver safe, structured treatment programs for addiction, TBI, and mental health conditions.
Why AJH Works With Ambio
Beōnd is the site of AJH’s breakthrough into the UK Rugby concussion cohort — a landmark moment in bringing entheogenic treatment to professional athletes dealing with the long-term effects of repeated head trauma. This partnership opened the door to rugby governing bodies and athlete networks across the UK.
What Athletes Experience
Comprehensive medical intake and contra-indication screening
Medically supervised ibogaine treatment with continuous monitoring
Therapeutic support before, during, and after dosing sessions
EEG neuroimaging as part of AJH research protocol
Structured integration planning and follow-up support
❋ Experience onward
“Legal Psilocybin Therapy for Athletes, Veterans, and Brain Health”
Location:
Portland, Oregon & Colorado, USA
Compounds:
Psilocybin
Microdosing protocols
About
Experience Onward is one of the first licensed psilocybin service centers in the United States, operating out of a 10-room facility just 20 minutes from the Portland International Airport. Founded by two-time Stanley Cup champion Daniel Carcillo—who overcame post-concussion syndrome, depression, and suicidal ideation through guided psilocybin therapy—Onward combines physician oversight, trauma-informed facilitation, and world-class wellness amenities to help clients heal, grow, and move forward with clarity. Their community-focused approach resonates with athletes, executives, veterans, and individuals recovering from concussions and mental health challenges.
Why AJH Works With Onward
Experience Onward is AJH’s direct research partner. In April 2025, AJH and Onward co-conducted a groundbreaking pilot study on psilocybin and traumatic brain injury—the first of its kind at a licensed U.S. service center. Eight athletes with long-term concussion symptoms underwent guided psilocybin sessions, with neuroimaging and psychological assessments facilitated by Onaya Science. Results showed measurable improvements in brain connectivity and psychological well-being, with study coordinator Niguel Netzband, MSc, leading data collection on the ground. As a U.S.-based, legally regulated center, Onward offers AJH athletes a domestic pathway to psilocybin therapy without the need for international travel.
What Athletes Experience
Pre-screening medical assessment and physician clearance before therapy
Individually tailored psilocybin dosing guided by licensed, trauma-informed facilitators
Group and individual ceremony options in a safe, regulated setting
Neuroimaging and bio-analysis as part of AJH’s research protocol
Integration coaching and aftercare support following the experience
Microdosing guidance and follow-up protocols for sustained brain health
❋ CLERKENWELL HEALTH
“Europe’s First Commercial Psychedelic Clinical Research Site”
Location:
London & Doncaster, United Kingdom
Compounds:
Psilocybin
5-MeO-DMT
MDMA
Methylone
Novel psychedelic compounds (multi-sponsor site)
Legal Status:
MHRA-approved clinical research organization conducting Phase I–IV trials under UK regulatory framework.
ABOUT
Clerkenwell Health is a specialist clinical research organization (CRO) and trial site network based in London, purpose-built for the next generation of mental health and neurological treatments. Unlike single-sponsor research sites, Clerkenwell works with multiple drug developers and biotech companies across a range of psychedelic and novel compounds. Their clinics are designed to feel welcoming and therapeutic rather than institutional, and they have delivered trials for clients including Beckley Psytech (5-MeO-DMT for treatment-resistant depression), Incannex (psilocybin for generalized anxiety disorder), and Mindset Pharma. Clerkenwell also runs a therapist training program to prepare practitioners for psychedelic-assisted therapy delivery.
Why AJH Works With Clerkenwell
Clerkenwell is AJH’s partner for UK-based clinical trials and future European expansion. As Europe’s first commercial facility dedicated to psychedelic-assisted therapies, Clerkenwell provides AJH with access to MHRA-regulated research infrastructure, diverse compound pipelines, and a trained therapist network—positioning AJH to extend its evidence base into international markets and support athletes across the UK and Europe.
What Athletes Experience
Access to cutting-edge clinical trials studying psychedelics for PTSD, depression, anxiety, and TBI
Comprehensive medical screening and monitoring under MHRA-approved protocols
Therapeutic support from practitioners specifically trained in psychedelic-assisted therapy
Purpose-built clinical environment designed for comfort and psychological safety
Contribution to peer-reviewed research advancing the evidence base for psychedelic medicine